All In Biotech

Drug Trial Radar · NCT02584257

Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma

Comparison of the Pharmacodynamic Profile of Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate Using Bronchoprovocation in Adult Patients With Stable Mild Asthma

Last checked: Nov 20, 2026Latest source record: Dec 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 217 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

217

Actual

Start

Apr 2016

Primary completion

Aug 2016

Study completion Sep 2016

Sponsor

Lead sponsor
Lupin, Inc.Industry
Sponsor type
Industry
First posted
Oct 22, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Double (participant, care provider)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product, using bronchoprovocation (methacholine challenge testing) in adult patients with stable mild asthma.

Conditions

  • Mild Persistent Asthma

Interventions

  • methacholine chlorideOther

  • placebo ProAir HFADrug

  • ProAir HFADrug

  • Lupin albuterol HFA MDIDrug

  • placebo Lupin albuterol HFA MDIDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Post-dose PC20 Concentration After Receiving Differing Doses of Test, Reference, or PlaceboTime frame: Post-dose at Visits 2-6 of the study, a total of approximately 4 weeks.

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Investigational Research Center Site #110

    Huntington Beach, California

  • Investigational Research Center Site #114

    Mission Viejo, California

  • Investigational Research Center Site #113

    Rolling Hills Estates, California

  • Investigational Research Center Site #112

    San Diego, California

  • Investigational Research Center Site #116

    San Jose, California

  • Investigational Research Center Site #106

    Tallahassee, Florida

  • Investigational Research Center Site #109

    Baltimore, Maryland

  • Investigational Research Center Site #105

    Bethesda, Maryland

  • Investigational Research Center Site #103

    North Dartmouth, Massachusetts

  • Investigational Research Center Site #108

    St Louis, Missouri

  • Investigational Research Center Site #115

    Bellevue, Nebraska

  • Investigational Research Center Site #104

    Skillman, New Jersey

  • Investigational Research Center Site #102

    Raleigh, North Carolina

  • Investigational Research Center Site #111

    Cincinnati, Ohio

  • Investigational Research Center Site #118

    Tulsa, Oklahoma

  • Investigational Research Center Site #101

    Medford, Oregon

  • Investigational Research Center Site #107

    Portland, Oregon

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.